Saturday, March 6, 2010

Street Cheers Prospects For InterMune Drug

Biotech's shares soar after unexpectedly supportive report on lung disease drug.
Read More... [Source: Forbes.com: Most popular stories - Posted by FreeAutoBlogger]

No comments:

Blog Archive